Reduction of Recurrence of Stroke by Nurse-led Education in Bangladesh
Launched by HIROSHIMA UNIVERSITY · Aug 26, 2022
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether education led by nurses can help reduce the chances of having another stroke for patients who have had their first stroke. Many people may not fully understand how to manage their health after a stroke, which can lead to a higher risk of having another one. By providing health education and teaching both patients and their family caregivers about lifestyle changes and how to monitor risk factors, the researchers hope to help patients avoid a second stroke.
To participate, you must be at least 18 years old and have had your first stroke, among other criteria. Family caregivers who live with the stroke patient and are willing to help with the study can also join. If you decide to take part, you can expect to receive valuable information and support from nurses that can help you manage your health better. It's important to know that this study is still looking for participants, and those interested will need to provide written consent to join.
Gender
ALL
Eligibility criteria
- • For patient
- • 1. Who was discharged from NINSH to home or who visited NINSH right after getting a stroke
- • 2. First-time stroke
- • 3. All types of strokes, except subarachnoid haemorrhage
- • 4. modified Rankin Scale (0 - 4)
- • 5. Stroke patient who is 18 years old and above
- • 6. Both males \& females
- • 7. Who provided written consent \& willing to participate in the study
- • For family caregivers
- • 1. Primary caregivers irrespective of sex and aged 18 years old and above, living with the patient who take care of an above patient and who meets all of the inclusion criteria (will be decided by one person)
- • 2. Who will provide written consent \& willing to participate in the study
- Exclusion Criteria:
- • Exclusion criteria of patient
- • 1. Who has stroke with the recurrence
- • 2. Stroke subtype: caused by genetic problems or injury/accident
- • 3. Patients with multi-organ failure or terminal stage
- • 4. Participation in other clinical trials
- • 5. Unwillingness to participate in the study
- • 6. Not having a mobile phone at home
- • 7. mRS 5
- • Exclusion criteria of caregiver
- • 1. Who is not living with the patient
- • 2. Who is under 18 years old
- • 3. Who is mentally unstable and/or cognitively impaired (diagnosed cases)
About Hiroshima University
Hiroshima University is a prestigious research institution in Japan, renowned for its commitment to advancing medical science and improving healthcare outcomes. With a strong focus on innovative clinical research, the university actively sponsors clinical trials aimed at developing novel therapies and enhancing patient care. Its multidisciplinary approach leverages expertise across various fields, fostering collaboration among researchers, clinicians, and industry partners. Through rigorous study design and adherence to ethical standards, Hiroshima University strives to contribute valuable insights to the global medical community while ensuring the highest level of participant safety and welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dhaka, , Bangladesh
Patients applied
Trial Officials
KATM Ehsanul Huq, PhD
Principal Investigator
Hiroshima University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials